Evidence map›Paper›PMID 32982424›Full record

ArticleCancer management and research2020

CircRNA Circ_0001721 Promotes the Progression of Osteosarcoma Through miR-372-3p/MAPK7 Axis.

Yuanpeng Gao, Haixia Ma, Yan Gao, Kai Tao, Liyan Fu, Ruimin Ren, Xingui Hu, Min Kou, Bin Chen, Junjun Shi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Osteosarcoma in a ceRNET perspective.Journal of biomedical science · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The roles of glycolysis in osteosarcoma.Frontiers in pharmacology · 2022
    Review
  18. HBV Promotes the Proliferation of Liver Cancer Cells through the hsa_circ_0000847/miR-135a Pathway.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Yuanpeng Gao *Department of Orthopaedics, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Haixia Ma *Department of Pathology, Tumor Hospital of Shanxi, Taiyuan, People's Republic of China.
Yan GaoDepartment of VitreoretinalSurgery, Shanxi Eye Hospital, Taiyuan, People's Republic of China.
Kai TaoDepartment of Digestive Minimally Invasive Surgery, Tumor Hospital of Shanxi, Taiyuan, People's Republic of China.
Liyan FuComprehensive Examination Department, Children's Hospital of Shanxi Province, Taiyuan, People's Republic of China.
Ruimin RenDepartment of Urology Surgery, Shanxi Bethune Hospital, Taiyuan, People's Republic of China.
Xingui HuDepartment of Cardiology, Taiyuan Iron and Steel Group General Hospital, Taiyuan, People's Republic of China.
Min KouDepartment of Nephrology, Children's Hospital of Shanxi Province, Taiyuan, People's Republic of China.
Bin ChenDepartment of Orthopaedics, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Junjun ShiDepartment of Orthopaedics, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Yunpeng WenDepartment of Rehabilitation, Shanxi Huajin Orthopedic Hospital, Taiyuan, People's Republic of China.
Shanxi Eye Hospital · CNShanxi Provincial Cancer Hospital · CNShanxi Provincial Children's Hospital · CNSecond Hospital of Shanxi Medical University · CNShanxi Academy of Medical Sciences · CNShanxi Medical University · CNTaiyuan Iron and Steel Group (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcoma (OS) is the most common bone tumor. Many studies have reported that circular RNAs (circRNAs) play an important role in the development of a variety of human cancers. However, the underlying mechanism of circ_0001721 in regulating osteosarcoma progression remains unknown. MATERIALS AND

methodsQuantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the levels of circ_0001721, miR-372-3p, and mitogen-activated protein kinase 7 (MAPK7) in osteosarcoma tissues and cells. Besides, glycolysis was investigated by glucose consumption, lactate production and hexokinase II (HK2) protein level. Cell proliferation and apoptosis were determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and flow cytometry, separately. Cell migration and invasion were determined by transwell assay. Moreover, the protein levels of HK2 and epithelial-to-mesenchymal transition (EMT) markers were determined by Western blot analysis. The relationship between miR-372-3p and circ_0001721 or MAPK7 was predicated by starbase v3.0 and confirmed by dual-luciferase reporter assay or RNA binding protein immunoprecipitation (RIP) assay. Murine xenograft model was established to investigate the role of circ_0001721 in vivo.

resultsThe levels of circ_0001721 and MAPK7 were upregulated in osteosarcoma tissues and cells, while miR-372-3p was downregulated. Knockdown of circ_0001721 inhibited glycolysis, cell proliferation, cell migration, invasion and epithelial-to-mesenchymal transition (EMT), and promoted apoptosis. Circ_0001721 was validated as a sponge of miR-372-3p and mediated glycolysis, cell proliferation, apoptosis, migration, invasion, and EMT of osteosarcoma cells through miR-372-3p. MAPK7 was a target of miR-372-3p and overexpression of MAPK7 attenuated anti-cancer role of miR-372-3p in OS cells. Further studies revealed that circ_0001721 regulates MAPK7 expression via sponging miR-372-3-p. Finally, knockdown of circ_0001721 inhibited tumor progression in vivo.

conclusionCirc_0001721 promoted osteosarcoma development through the miR-372-3p/MAPK7 axis.

Indexed as

circ_0001721MAPK7miR-372-3posteosarcoma

Identifiers

PMID32982424
PMCPMC7498501
OpenAlexW3083892454

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.